Fludarabine and busulfan as a reduced-toxicity myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation for acute leukemia patients

समान संसाधन

• Comparative effectiveness of busulfan/cyclophosphamide versus busulfan/fludarabine myeloablative conditioning for allogeneic hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome
  द्वारा: Sagar S. Patel, और अन्य
  प्रकाशित: (2020-09-01)
• Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine
  द्वारा: Harris, Andrew C., और अन्य
  प्रकाशित: (2018)
• Myeloablative reduced-toxicity IV busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life
  द्वारा: Alatrash, Gheath, और अन्य
  प्रकाशित: (2011)
• Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study
  द्वारा: Liu, Hui, और अन्य
  प्रकाशित: (2013)
• Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia
  द्वारा: Dhere, Vishal, और अन्य
  प्रकाशित: (2017)